Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro
- PMID: 1618053
- DOI: 10.1007/BF01300287
Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro
Abstract
The effect of acarbose on hydrolysis of a pure starch meal was investigated in normal subjects and ileostomy patients by means of 13CO2 breath tests and blood glucose levels as parameters of absorption, and of H2 breath tests, serum acetate levels, and ileal loss of carbohydrate as parameters of malabsorption. Additional information on the effect of acarbose on alpha-amylase activity was obtained by in vitro experiments. Acarbose (200 and 400 mg) significantly delayed starch absorption. Serum acetate was found to be a less sensitive marker of malabsorption than breath H2 excretion. After intake of 50 g starch plus 400 mg acarbose, 23-71% of the starch load was lost in the ileostomy effluent, for a large part as starch. This suggests that acarbose considerably inhibits alpha-amylase, and not only brush-border enzymes. In vitro experiments confirm that an inhibition of two thirds of alpha-amylase activity can be expected from pharmacologically used doses of acarbose.
Similar articles
-
A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.Drug Saf. 1994 Dec;11(6):432-44. doi: 10.2165/00002018-199411060-00005. Drug Saf. 1994. PMID: 7727053 Review.
-
Scope and specificity of acarbose in slowing carbohydrate absorption in man.Diabetes. 1981 Nov;30(11):951-4. doi: 10.2337/diab.30.11.951. Diabetes. 1981. PMID: 7028548
-
Georges Brohee Prize 1988-1989. Assimilation of nutritional carbohydrates: influence of hydrolysis.Acta Gastroenterol Belg. 1991 Jan-Feb;54(1):3-11. Acta Gastroenterol Belg. 1991. PMID: 2058348
-
Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.Am J Clin Nutr. 1985 Mar;41(3):511-6. doi: 10.1093/ajcn/41.3.511. Am J Clin Nutr. 1985. PMID: 3883743
-
Pharmacology of alpha-glucosidase inhibition.Eur J Clin Invest. 1994 Aug;24 Suppl 3:3-10. Eur J Clin Invest. 1994. PMID: 8001624 Review.
Cited by
-
Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations.Nutrients. 2019 Jun 25;11(6):1436. doi: 10.3390/nu11061436. Nutrients. 2019. PMID: 31242690 Free PMC article.
-
A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.Drug Saf. 1994 Dec;11(6):432-44. doi: 10.2165/00002018-199411060-00005. Drug Saf. 1994. PMID: 7727053 Review.
-
Acarbose glycosylation by AcbE for the production of acarstatins with enhanced α-amylase inhibitory activity.Synth Syst Biotechnol. 2024 Mar 15;9(2):359-368. doi: 10.1016/j.synbio.2024.03.006. eCollection 2024 Jun. Synth Syst Biotechnol. 2024. PMID: 38559426 Free PMC article.
-
White common bean extract remodels the gut microbiota and ameliorates type 2 diabetes and its complications: A randomized double-blinded placebo-controlled trial.Front Endocrinol (Lausanne). 2022 Oct 11;13:999715. doi: 10.3389/fendo.2022.999715. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36303868 Free PMC article. Clinical Trial.
-
Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial.Diabetes Ther. 2017 Apr;8(2):293-307. doi: 10.1007/s13300-017-0226-y. Epub 2017 Jan 27. Diabetes Ther. 2017. PMID: 28130771 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical